World's Best Scientists 2026 revealed!
Alessandro Lugli

Alessandro Lugli

D-Index & Metrics

Medicine

D-Index
80
Citations
23898
World Ranking
17095
National Ranking
258

Overview

Alessandro Lugli is affiliated with the University of Bern in Switzerland and has a research focus primarily within the field of Medicine, with a substantial emphasis on Oncology. The scientist's work is distributed across several subfields including Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, and Artificial Intelligence.

The research topics that Alessandro Lugli engages with involve colorectal cancer surgical treatments, cancer immunotherapy and biomarkers, radiomics and machine learning in medical imaging, colorectal cancer treatments and studies, colorectal cancer screening and detection, genetic factors in colorectal cancer, and the application of artificial intelligence in cancer detection.

Frequent publication venues for Alessandro Lugli's work include:

  • Bern Open Repository and Information System (University of Bern)
  • Modern Pathology
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Cancers
  • Journal of Clinical Oncology

Recent notable papers authored by Alessandro Lugli or in collaboration with co-authors include:

  • "Tumour budding in solid cancers", 2020, Nature Reviews Clinical Oncology
  • "Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer", 2020, Journal of Clinical Oncology
  • "Tumour budding and its clinical implications in gastrointestinal cancers", 2020, British Journal of Cancer
  • "Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study", 2023, The Lancet Oncology
  • "Improving tumor budding reporting in colorectal cancer: a Delphi consensus study", 2021, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Co-authors who frequently collaborate with Alessandro Lugli include Inti Zlobec, Heather Dawson, Iris D. Nagtegaal, Martin D. Berger, and Richard Kirsch.

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Frequent EpCam protein expression in human carcinomas.

    Philip T.H Went;Alessandro Lugli;Sandra Meier;Marcel Bundi

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

    Alessandro Lugli;Richard Kirsch;Yoichi Ajioka;Fred Bosman

  • Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

    Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey

  • High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

    Daniel M. Frey;Raoul A. Droeser;Carsten T. Viehl;Inti Zlobec

  • Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

    A Lugli;G Iezzi;I Hostettler;M G Muraro

  • Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

    Inti Zlobec;Alessandro Lugli

  • Prevalence of KIT expression in human tumors

    Philip Th Went;Stephan Dirnhofer;Marcel Bundi;Martina Mirlacher

  • Prognostic and predictive factors in colorectal cancer

    Inti Zlobec;Alessandro Lugli

  • Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.

    Inti Zlobec;Michel P. Bihl;Heike Schwarb;Luigi Terracciano

  • Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

    Enric Domingo;Enric Domingo;Luke Freeman-Mills;Emily Rayner;Mark Glaire

  • Tumor budding in colorectal cancer—ready for diagnostic practice?

    Viktor H. Koelzer;Inti Zlobec;Alessandro Lugli

  • Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles

    P. Minoo;I. Zlobec;M. Peterson;L. Terracciano

  • Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.

    Pia Huusko;Damaris Ponciano-Jackson;Maija Wolf;Jeff A. Kiefer

  • Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality

    Claude A. Fischer;Inti Zlobec;Edith Green;Simone Probst

  • Tumour budding in solid cancers

    Alessandro Lugli;Inti Zlobec;Martin D Berger;Richard Kirsch

  • Selecting immunohistochemical cut‐off scores for novel biomarkers of progression and survival in colorectal cancer

    Inti Zlobec;Russell Steele;Luigi Terracciano;Jeremy R Jass

  • Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer

    A C Rogers;D C Winter;A Heeney;D Gibbons

Frequent Co-Authors

Inti Zlobec
Inti Zlobec University of Bern
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Aurel Perren
Aurel Perren University of Bern
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Jeremy R. Jass
Jeremy R. Jass Imperial College London
Yutaka Kawakami
Yutaka Kawakami International University Of Health And Welfare Atami Hospital
Toshihiko Torigoe
Toshihiko Torigoe Sapporo Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean attending medical school. Many students consider degrees in nursing and related healthcare fields, with flexible online programs making these pathways more accessible than ever. The rise of online nursing school options allows aspiring professionals to study and gain qualifications remotely, often while working.

Affordability is a significant concern for prospective healthcare students. For example, those seeking advanced credentials can find the cheapest dnp online program to enhance their expertise without accumulating overwhelming debt. Likewise, registered nurses looking to further their careers can research the cheapest rn to bsn online programs to seamlessly earn bachelor’s degrees online.

For individuals with non-nursing backgrounds who are drawn to advanced clinical roles, some institutions now offer direct entry nurse practitioner programs for non-nurses online. These innovative programs help students enter specialized roles quickly and efficiently. Exploring these online degree and certification pathways can be a strategic alternative for those interested in impactful healthcare careers beyond traditional medicine.

Best Scientists Citing Alessandro Lugli

Trending Scientists